ZALTRAP Injection for intravenous use (ziv - aflibercept)

What is Zaltrap (ziv-aflibercept)
Zaltrap is an anti-neoplastic agent, that is a Tyrosine Kinase inhibitor.

Zaltrap

Drug Manufacturer / Marketeer :

M/s Sanofi


Available as:

100MG / 200MG VIAL.

Indications:
Zaltrap is indicated in combination with 5-fluorouracil, leucovorin, irinotecan (FOLFIRI) for metastatic colorectal cancer that is resistant to or has progressed after an oxaliplatin regimen.

Treatment:
For treatment related information, please consult your treating Physician.

How supplied:
Zaltrap is supplied in a carton containing (1) single use vial of 100 mg per 4 ml (25 mg/ml)
Zaltrap is supplied in a carton containing (1) single use vial of 200 mg per 8 ml (25 mg/ml)

Storage and handling:
Store Zaltrap vials in a refrigerator at 2°- 8° C. Keep the vials in the original outer carton to protect from light.

How do we source the Drug?
SMIQ Pharma will assist in sourcing the drug through its efficient network, across the globe, and ensure the delivery is prompt. However, a valid prescription from the treating Oncologist is mandatory, with all relevant documents associated with its procurement is also essential.

Company that Manufactures/ Markets:
M/s Sanofi.

Assistance Cell in India:
For ONCOLOGY DRUG: ZALTRAP Injection for intravenous use (ziv – aflibercept) 100MG / 200MG price.

Contact us @ +91 7678048225 or by email  info@smiqpharma.com.